Family Medicine · Garden Grove, CA
NPI
1144255019
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
10741 Westminster Ave, Suite 100
Garden Grove, CA, 92843
Phone (714) 537-9181
Medicare paid, 2024
$704K
12,805 services
Medicare patients, 2024
790
Average age 76
Drug cost, 2024
$5.9M
51,112 prescriptions
Company payments, 2025
$3,635
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary A Tran was code 99213 (office e&m - established), 2,478 times for 636 patients. In total Mary A Tran billed 12,805 services in 54 codes, and Medicare paid $704K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,478 | 636 | $70.85 | $176K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,456 | 272 | $48.90 | $120K |
| 99214 Office E&M - Established | Office | 1,672 | 647 | $83.09 | $139K |
| 96372 Injection Administration | Office | 1,173 | 341 | $11.24 | $13K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,140 | 331 | $0.90 | $1,021 |
| 36415 Venipuncture Blood Collection | Office | 789 | 491 | $8.65 | $6,825 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 440 | 440 | $140.29 | $62K |
| 99232 Hospital E&M - Subsequent | Facility | 330 | 56 | $62.72 | $21K |
| G0008 Administration of influenza virus vaccine | Office | 295 | 294 | $34.30 | $10K |
| 99309 SNF E&M | Facility | 271 | 53 | $86.06 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 248 | 59 | $97.08 | $24K |
| 99212 Office E&M - Established | Office | 187 | 137 | $44.48 | $8,317 |
| 93000 Electrocardiogram | Office | 158 | 141 | $9.84 | $1,554 |
| 99223 Hospital E&M - Initial | Facility | 145 | 92 | $142.33 | $21K |
| 90658 Vaccine Product | Office | 141 | 141 | $21.42 | $3,020 |
By year: 2022 $711K for 13,186 services; 2023 $812K for 13,016 services; 2024 $704K for 12,805 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 789 | 491 | $8.65 | $6,825 |
| 83518 Immunoassay | 74 | 52 | $9.45 | $699 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary A Tran prescribed most often to Medicare patients was Amlodipine Besylate, with 2,235 prescriptions and refills. In total Mary A Tran wrote 51,112 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 2,235 | 4,698 | 513 | $7,581 |
| Atorvastatin Calcium Generic | 1,882 | 4,068 | 430 | $12K |
| Rosuvastatin Calcium Generic | 1,802 | 4,076 | 426 | $19K |
| Losartan Potassium Generic | 1,698 | 3,606 | 359 | $11K |
| Montelukast Sodium Generic | 1,452 | 2,460 | 498 | $9,974 |
| Gabapentin Generic | 1,247 | 1,904 | 357 | $9,667 |
| Metformin Hcl Generic | 1,214 | 2,795 | 287 | $7,374 |
| Celecoxib Generic | 1,106 | 1,391 | 399 | $16K |
| Famotidine Generic | 967 | 1,831 | 243 | $5,423 |
| Omeprazole Generic | 930 | 1,747 | 275 | $4,894 |
| Donepezil Hcl Generic | 878 | 1,743 | 242 | $6,380 |
| Pantoprazole Sodium Generic | 863 | 1,455 | 230 | $6,789 |
| Metoprolol Succinate Generic | 853 | 1,785 | 188 | $8,782 |
| Alendronate Sodium Generic | 756 | 1,595 | 187 | $4,283 |
| Tamsulosin Hcl Generic | 753 | 1,569 | 189 | $7,263 |
Brand drugs: 8,181 claims; generic drugs: 42,403 claims; opioid claims: 424.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary A Tran $3,635 ($3,635 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $803.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $803 |
| Amgen Inc. AMGN | 9 | $338 |
| GlaxoSmithKline, LLC. GSK | 13 | $275 |
| Abbvie Inc. ABBV | 13 | $237 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $222 |
| Gilead Sciences, Inc. GILD | 3 | $193 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $174 |
| Dexcom, Inc. DXCM | 3 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.